Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Patch Safety Study
NCT01655082Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Aug 2012
- Primary completion
- Oct 2012
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of V0116 in Tobacco Use Disorder (TUD), sponsored by Pierre Fabre Laboratories. Started Aug 2012; status: completed.
02
Drugs
V0116
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01655082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655082.